MAPS
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Apr 2024)
What this means for you
This application is over — abandoned 08 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88659855
- Mark type
- Stylized text
- Filed
- 18 Oct 2019
- Published for opposition
- 05 Jan 2021
- Abandoned
- 08 Apr 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens
Owner
- Affinivax, Inc., Wilmington, DE, US
- Affinivax, Inc., Lexington, MA, US
Prosecution history
- 08 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Oct 2023 — CORRECTED NOA E-MAILED
- 03 Oct 2023 — DIVISIONAL PROCESSING COMPLETE
- 22 Sept 2023 — DIVISIONAL REQUEST RECEIVED
- 22 Sept 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2023 — SOU EXTENSION 5 GRANTED
- 31 Aug 2023 — SOU EXTENSION 5 FILED
- 11 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 24 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Feb 2023 — SOU EXTENSION 4 GRANTED
- 22 Feb 2023 — SOU EXTENSION 4 FILED
- 22 Feb 2023 — SOU TEAS EXTENSION RECEIVED